Comparison of different histopathological methods for the examination of sentinel lymphnodes in breast cancer

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2209-2212

  Nahrig J ^a   Richter, T ^a   Kowolik, J ^a   Kuhn, W ^a   Avril, N ^a   Hofler H ^a   Werner, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Frozen section; Sentinel lymphnode; Serial section; Ultrarapid immunohistochemistry

Indexed keywords

ANTIBODY; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; ANTIGENS, NEOPLASM; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; COLORING AGENTS; EOSINE YELLOWISH-(YS); FEMALE; FROZEN SECTIONS; HEMATOXYLIN; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MICROTOMY; MIDDLE AGED; PARAFFIN EMBEDDING; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; STAINING AND LABELING;

EID: 0342646991     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mustafa IA and Bland KI: Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol 15(1): 4-8, 1998.
2. Giuliano AE, Barth AM, Spivack B et al: Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 183(3): 185-9, 1996.
3. Giuliano AE, Kirgan DM, Guenther JM and Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3): 391-8, 1994.
4. Veronesi U, Paganelli G, Galimberti V et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 28, 349(9069): 1864-7, 1997.
5. Krag D, Weaver D, Ashikaga T et al: The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1, 339(14): 941-6, 1998.
6. Giuliano AE, Jones RC, Brennan M et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15(6): 2345-50, 1997.
7. Turner RR, Ollila DW, Krasne DL and Giuliano AE: Histopathologic validation of the sentinel lymphnode hypothesis for breast carcinoma. Ann Surg 226(3): 271-6, 1997.
8. Meyer JS: Sentinel lymphnode biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 69(4): 212-8, 1998.
9. Turner RR, Ollila DW, Stern S and Giuliano AE: Optimal histopathologic examination of the sentinel lymphnode for breast carcinoma staging. Am J Surg Pathol 23(3): 263-7, 1999.
10. Richter T, Nährig J, Komminoth P, Kowolik et al: Protocol for ultrarapid immunostaining of frozen sections. J. Clin. Pathol 52: 461-463, 1999.
11. Nasser IA, Lee AK, Bosari S, Saganich R et al: Occult axillary lymphnode metastases in "node-negative" breast carcinoma. Hum Pathol 24(9): 950-7, 1993.
12. Dowlatshahi K, Fan M, Snider HC and Habib FA: Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1, 80(7): 1188-97, 1997.
13. UICC: TNM classification of malignant tumors. 5th ed (Sobin H and Wittekind Ch, ed.). New York, John Wiley & Sons, 1997.
14. UICC: TNM Supplement. A commentary on uniform use (Hermanek P, Henson DE, Hutter RVP, Sobin LH, eds). Berlin, Heidelberg, New York, Tokio, Springer, 1993.
15. Hermanek P: Disseminated tumor cells versus micrometastasis: definitions and problems. Anticancer Res 19(4A): 2771-4, 1999.
16. Czerniecki BJ, Scheff AM, Callans LS et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1, 85(5): 1098-103, 1999.
17. Trojani M, de Mascarel I, Bonichon F et al: Micrometastases to axillary lymphnodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 55(3): 303-6, 1987.
18. Sedmak DD, Meineke TA, Knechtges DS et al: Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2(5): 516-20, 1989.
19. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymphnode micrometastases from breast cancers. Lancet 30, 335(8705): 1565-8, 1990.
20. Luzzi KJ, MacDonald IC, Schmidt EE et al: Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153(3): 865-73, 1998.
21. Cote RJ, Peterson HF, Chaiwun B et al: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 11, 354(9182): 896-900, 1999.
22. de Mascarel I, Bonichon F, Coindre JM et al: Prognostic significance of breast cancer axillary lymphnode micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66(3): 523-7, 1992.
23. Friedman S, Bertin F, Mouriesse H et al: Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 27(5): 483-7, 1988.